Platelet microRNAs as Potential Novel Biomarkers for Antiplatelet Therapy with P2Y12 Inhibitors and Their Association with Platelet Function
Journal of Clinical Medicine · 22.12.2023 · 13 (1) · 63
DOI: 10.3390/jcm13010063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.12.2023. Verfasst von Karolina Gumiężna und 9 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Cardiology, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) require dual antiplatelet therapy (DAPT). However, the response to treatment can vary considerably. Certain platelet microRNAs (miRs) are suspected to predict DAPT response and influence platelet function. This study aimed to analyze selected miRs’ expressions and compare them among patients treated with different P2Y12 inhibitors while assessing their association with platelet activity and turnover parameters. Materials and methods: We recruited 79 ACS patients post-PCI treated with clopidogrel, ticagrelor, or prasugrel, along with 18 healthy volunteers. Expression levels of miR-126-3p, miR223-3p, miR-21-5p, miR-197-3p, and miR-24-3p, as well as immature platelet fraction (IPF) and ADP-induced platelet reactivity, were measured and compared between groups.
Results
Analyses revealed significantly lower expressions of miR-126-3p, miR-223-3p, miR-21-5p, and miR-197-3p in patients treated with ticagrelor, compared to clopidogrel (fold changes from −1.43 to −1.27, p-values from 0.028 to 0.048). Positive correlations were observed between platelet function and the expressions of miR-223-3p (r = 0.400, p = 0.019) and miR-21-5p (r = 0.423, p = 0.013) in patients treated with potent drugs. Additionally, miR-24-3p (r = 0.411, p = 0.012) and miR-197-3p (r = 0.333, p = 0.044) showed correlations with IPF.
Conclusions
The identified platelet miRs hold potential as biomarkers for antiplatelet therapy. (ClinicalTrials.gov number, NCT06177587).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Department of Cardiology, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland.
- Department of Clinical Chemistry and Laboratory Diagnostics, Medical University of Warsaw, 02-097 Warsaw, Poland.
- Department of Cardiology, Hypertension and Internal Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland.
- Department of Immunology, Transplantation and Internal Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland.
ORCID-Profile: Karolina Gumiężna, Adrian Bednarek, Grażyna Sygitowicz, Agata Maciejak-Jastrzębska, Jaromir Hunia, Mariusz Tomaniak
Zitieren
APA
Gumiężna, K., Bednarek, A., Sygitowicz, G., Maciejak-Jastrzębska, A., Baruś, P., Hunia, J., Klimczak-Tomaniak, D., Kochman, J., Grabowski, M., & Tomaniak, M. (2023). Platelet microRNAs as Potential Novel Biomarkers for Antiplatelet Therapy with P2Y12 Inhibitors and Their Association with Platelet Function. Journal of Clinical Medicine, 13(1), 63. https://doi.org/10.3390/jcm13010063
Vancouver
Gumiężna K, Bednarek A, Sygitowicz G, Maciejak-Jastrzębska A, Baruś P, Hunia J, et al. Platelet microRNAs as Potential Novel Biomarkers for Antiplatelet Therapy with P2Y12 Inhibitors and Their Association with Platelet Function. Journal of Clinical Medicine. 2023;13(1):63. doi:10.3390/jcm13010063
BibTeX
@article{Gumina2023,
author = {Gumiężna, Karolina and Bednarek, Adrian and Sygitowicz, Grażyna and Maciejak-Jastrzębska, Agata and Baruś, Piotr and Hunia, Jaromir and Klimczak-Tomaniak, Dominika and Kochman, Janusz and Grabowski, Marcin and Tomaniak, Mariusz},
title = {Platelet microRNAs as Potential Novel Biomarkers for Antiplatelet Therapy with P2Y12 Inhibitors and Their Association with Platelet Function},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {13},
number = {1},
pages = {63},
doi = {10.3390/jcm13010063}
}
EUVIMED